These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1518958)
61. Effects of isoproterenol infusion on myocardial structure and composition. Barner HB; Jellinek M; Kaiser GC Am Heart J; 1970 Feb; 79(2):237-43. PubMed ID: 5410954 [No Abstract] [Full Text] [Related]
62. Lacticodehydrogenase release from perfused rat heart under the effect of abnormal media. de Leiris J; Breton D; Feuvray D; Coraboeuf E Arch Int Physiol Biochim; 1969 Oct; 77(4):749-62. PubMed ID: 4188413 [No Abstract] [Full Text] [Related]
63. Direct toxic effect of isoproterenol on cultured cardiac muscle cells. Severin E; Sartore S; Schiaffino S Experientia; 1977 Nov; 33(11):1489. PubMed ID: 923720 [TBL] [Abstract][Full Text] [Related]
64. [The mechanism of decrease in the cardiotoxic effect of isoprenaline with repeated use]. Maramaa SIa; Khaage SA Kardiologiia; 1972 Sep; 12(9):43-7. PubMed ID: 4644952 [No Abstract] [Full Text] [Related]
65. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Zimmerman AN; Hülsmann WC Nature; 1966 Aug; 211(5049):646-7. PubMed ID: 5968741 [No Abstract] [Full Text] [Related]
66. The healing of frog heart lesions induced by isoproterenol injections. Carlsten A; Ericson LE; Poupa O Acta Pathol Microbiol Immunol Scand A; 1982 Jan; 90(1):57-65. PubMed ID: 6979158 [TBL] [Abstract][Full Text] [Related]
67. Effect of nitroglycerin and a nitroglycerin-like substance in isoprenaline (ISO) necrosis and hypoxia. Vértesi C; Knopf E; Körmöczy PS Acta Physiol Hung; 1990; 75 Suppl():291-2. PubMed ID: 2115234 [No Abstract] [Full Text] [Related]
68. Prevention of the cardiotoxic effect of quinidine by isoproterenol. GOTTSEGEN G; OSTOR E Am Heart J; 1963 Jan; 65():102-9. PubMed ID: 13949513 [No Abstract] [Full Text] [Related]
69. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Angelone T; Quintieri AM; Brar BK; Limchaiyawat PT; Tota B; Mahata SK; Cerra MC Endocrinology; 2008 Oct; 149(10):4780-93. PubMed ID: 18535098 [TBL] [Abstract][Full Text] [Related]
70. Direct effects of streptokinase on the isolated rat myocardium. Puckett SW; Digerness SB; Bowdon HR; Rogers WJ; Rackley CE J Cardiovasc Pharmacol; 1984; 6(6):1120-3. PubMed ID: 6084769 [TBL] [Abstract][Full Text] [Related]
71. Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury. Sangeetha T; Darlin Quine S J Pharm Pharmacol; 2006 May; 58(5):617-23. PubMed ID: 16640830 [TBL] [Abstract][Full Text] [Related]
72. Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMP-dependent pathway. Li HY; Bian JS; Kwan YW; Wong TM J Pharmacol Exp Ther; 2000 May; 293(2):592-8. PubMed ID: 10773033 [TBL] [Abstract][Full Text] [Related]
73. Comparative study of isoproterenol and 4-deoxypyridoxine effects on the isovolumic rat heart model. Lorenzato M; Millart H; Albert O In Vivo; 1990; 4(3):195-9. PubMed ID: 1966802 [TBL] [Abstract][Full Text] [Related]
74. The effects of isoproterenol on the isolated perfused rat heart. Abbott D; Lodola A Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):125-8. PubMed ID: 1518958 [TBL] [Abstract][Full Text] [Related]